Back to Results
First PageMeta Content
Food and Drug Administration / Bristol-Myers Squibb / Cetuximab / Chemical pathology / KRAS / Center for Drug Evaluation and Research / Panitumumab / Pathology / Medical laboratory scientist / Medicine / Health / Pharmacology


Microsoft Word - FDA Letter_RxDrugLabeling_March2013
Add to Reading List

Document Date: 2013-03-22 09:34:16


Open Document

File Size: 81,36 KB

Share Result on Facebook
UPDATE